Jan. 27 at 2:06 PM
$TECH "Heads up alert! Upcoming earnings on Friday, 1/30/2026 for
$TECH
Bearish (2.5)
---
In evaluating Bio-Techne Corporation (NASDAQ: TECH), several key financial metrics and recent performance indicators suggest a cautious outlook.
The company's P/E ratio currently stands at approximately 35, which is notably higher than the industry average of 25, indicating that the stock may be overvalued given its recent struggles with organic growth and free cash flow margins.
The latest reports indicate a projected EPS growth rate of -1.5% for the upcoming quarter, reflecting expectations of a profit dip amidst concerns over cash flow sustainability.
Revenue forecasts suggest a modest increase of 3% year-over-year, which is below the industry average of 7%, further emphasizing the company's challenges.
Additionally, Bio-Techne's one-year total shareholder return has declined by approximately 18%, contrasting sharply with a 10% increase in the broader healthcare sector, highlighting underperformance relative to its peers.
Looking ahead to the upcoming earnings report, analysts anticipate a challenging quarter for Bio-Techne, with expectations of a single-digit profit decline.
Historical performance reveals that the company has consistently missed earnings expectations in the past year, creating a cautious sentiment among investors.
Analyst consensus estimates suggest a revenue of around
$220 million, with an EPS of
$0.75, which may not meet the market's elevated expectations, particularly given the recent downgrade and concerns regarding cash flow.
The potential impact of these results could further depress the stock price if the company fails to demonstrate improvement in its financial health and operational efficiency.
Overall, the healthcare sector is currently experiencing a mixed performance, with certain segments thriving due to advancements in technology and innovation.
However, Bio-Techne's recent struggles with growth and profitability have placed it in a precarious position within this dynamic environment, leading to a bearish consensus among analysts and investors alike.
- Funds were net sellers of
$TECH during the previous reporting quarter.
- Funds with large holdings in
$TECH include:
- Adage Capital P, MV:
$8MM. Fund Rank: 86%
www.adagecapital.com
- Last 10 days performance: 9%
- Last 30 days performance: 21%
- Last 90 days performance: 8%
Some of the latest news articles:
- Title: 3 Cash-Producing Stocks That Fall Short
Publication Date: 1/23/2026 4:35:08 AM, Source: yahoo
URL: https://finance.yahoo.com/news/3-cash-producing-stocks-fall-043508179.html?.tsrc=rss
- Title: 1 High-Flying Stock for Long-Term Investors and 2 That Underwhelm
Publication Date: 1/21/2026 4:33:54 AM, Source: yahoo
URL: https://finance.yahoo.com/news/1-high-flying-stock-long-043354749.html?.tsrc=rss
- Title: Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results
Publication Date: 1/20/2026 12:00:00 PM, Source: yahoo
URL: https://finance.yahoo.com/news/bio-techne-host-conference-call-120000254.html?.tsrc=rss
- Title: Here's What to Expect From Bio-Techne's Next Earnings Report
Publication Date: 1/9/2026 1:37:56 PM, Source: yahoo
URL: https://www.barchart.com/story/news/36967181/here-s-what-to-expect-from-bio-techne-s-next-earnings-report?.tsrc=rss
Follow us on stocktwits.com for more earnings alerts. Not a financial advice. Not a trading signal."
